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Abstract
We present the case of a 66 year old male who pre-
sented with dyspnea and reduced exercise tolerance. 
Echocardiography demonstrated impaired left ventricu-
lar (LV) function and restrictive diastolic function with 
pronounced concentric left ventricular hypertrophy 
(LVH) without a history of hypertension and no aortic 
valve stenosis. Differential diagnostics of concentric 
LVH are discussed in detail. In the current case, cardiac 
amyloidosis (AL) amyloidosis was diagnosed and con-
firmed by serum amyloid P (SAP) scintigraphy and ab-
dominal fat aspiration biopsy. This case shows the rapid 
decline in clinical condition with progression of cardiac 
involvement of AL. As discussed in detail, cardiac in-
volvement in AL-amyloidosis generally denotes a poor 
prognosis, regardless of the method of treatment. 
© 2013 Baishideng. All rights reserved.
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INTRODUCTION
Amyloidosis is a disease that is characterised by the extra-
cellular deposition of  proteinaceous material (amyloid). 
A distinction has to be made between the (rare) AM-
amyloidosis and the more common AL-amyloidosis on 
which this report will focus.
CASE REPORT
A 66-year old man was referred to our outpatient clinic for 
a second opinion because of  slowly increasing shortness 
of  breath on exertion, fatigue and reduced exercise toler-
ance over the previous year. His medical history included a 
non-ST segment elevation myocardial infarction with pre-
served left ventricular (LV) function and mild chronic ob-
structive pulmonary disease. Family history did not reveal 
any cardiovascular diseases or sudden cardiac death. On 
physical examination, blood pressure was 130/80 mmHg, 
a third heart sound was detected but there were no signs 
of  heart failure. Electrocardiography showed microvoltag-
es in the limb leads, a first degree atrio-ventricular block 
and Q-waves in the anterior and inferior wall leads. Labo-
ratory tests revealed a ferriprive anaemia Hb 6.6; normal 
(N) = 8.5-11.0 mmol/L), elevated creatinine (150 µmol/L, 
N < 100 µmol/L), γ-glutamyltransferase (292 U/L, N 
< 35 E/L) and alkaline phosphatase (200 U/L, N < 120 
E/L). Previous echocardiography 8 years before presenta-
tion demonstrated preserved LV function with ejection 
fraction (EF) of  64%, concentric LV hypertrophy with a 
width of  the interventricular septum (IVS) and LV poste-
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rior wall of  18 and 12 mm, respectively. Diastolic function 
was normal (E/A ratio 0.80; Evel 0.49 m/s; Avel 0.61 m/s) 
with a normal right ventricular systolic pressure (RVSP). 
Subsequent echocardiograms demonstrated a progressive 
decline in EF, progressive diastolic dysfunction to grade 
Ⅱ and pronounced concentric LV hypertrophy (LVH) 
without sparkling. During follow-up the patient remained 
asymptomatic until the year before his appearance at 
our centre. At presentation, echocardiography showed a 
moderately impaired LV function (EF 34%) with a spar-
kling IVS of  19 mm diameter. Diastolic dysfunction had 
worsened to grade Ⅲ with E/A ratio of  1.8 [E-vel 0.80 
A-vel 0.57; S’ 3.5 cm/s (N > 5 cm/s); E/E’ ratio 26.2 (N 
< 15)] with an increased RVSP of  41 mmHg with mod-
erate tricuspid insufficiency (Figure 1). Values of  S’ and 
E/E’ reflected the poor systolic function and raised filling 
pressures in our patient. The decline in ejection fraction 
and pronounced concentric LVH without a history of  
hypertension or aortic valve stenosis on echocardiography 
with new complaints of  exertional dyspnea were reasons 
for further investigation to rule out or demonstrate other 
causes of  concentric LVH such as amyloidosis, Fabry’s dis-
ease etc.[1,2]. Blood tests showed no para-proteinemia, but 
free light chains were found in urine (0.06 g/L) and serum 
samples. Based on the latter finding AL-amyloidosis was 
suspected[1,2]. This diagnosis was confirmed by serum 
amyloid P (SAP) scintigraphy (Figure 2) and abdominal 
fat aspiration biopsy (Figure 3). Bone biopsy revealed mild 
clonal plasma cell dyscrasia with excess of  light chains 
and total plasma cells of  5 %. Cardiac magnetic resonance 
imaging (CMR) confirmed cardiac involvement with areas 
of  fibrosis in the inferolateral wall[1,2]. Upon diagnosis, 
chemotherapy with Melfalan, Thalidomide and predniso-
lone was initiated according to the Palumbo-schedule[3,4]. 
Chemotherapy did not have any effect on the clinical 
condition and nine months after the diagnosis of  cardiac 
amyloidosis, the patient died of  heart failure. 
Brugts JJ et al . Echocardiography and cardiac AL-amyloidosis
155 May 26, 2013|Volume 5|Issue 5|WJC|www.wjgnet.com
A B
DC
Figure 1  Transthoracic echocardiography images. A: Parasternal long axis view diastolic still frame demonstrating thickened myocardium 
with sparkling of the septum. IVSd 19 mm, LPWd 19 mm; B: Apical four chamber view end diastolic still frame demonstrating thickened myo-
cardium and normal appearance of heart valves; C: PW Doppler measurement of MV inflow. MV E/A ratio 1.8; E-vel 0.80; A-vel 0.57; IVRT 77 
ms; dt 224 ms; D: Tissue Doppler Imaging with PW Doppler measurement on medial annulus of MV with E’ 3 cm/s E/E’ ratio 26.2 confirming 
the diastolic dysfunction. S’ 3.5 cm/s associated with impaired left ventricular function. 
Figure 2  Serum amyloid P scintigraphy 24 h after intravenous injection 
of 123I-serum amyloid P. Serum amyloid P (SAP) scintigraphy 24 h after intra-
venous injection of 123I-SAP. Total body uptake from the side (left image) and 
back (right image). Normal blood pool activity is present in organs such as liver, 
heart, and kidneys. Intense uptake is present in the spleen.
DISCUSSION 
In AL-amyloidosis the amyloid is produced by clonal light 
chains made by disrupted plasma cells (plasma cell dyscra-
sia). The extracellular deposition of  AL-amyloid can occur 
in all tissues and organs, but predominates in heart, liver 
and kidney[3-5]. Cardiac involvement can vary from being 
absent to severe and is present in approximately 50% of  
cases. In half  of  these cases congestive heart failure (CHF) 
is the presenting symptom and when CHF is present, 
median survival is less than six months in untreated pa-
tients[3-5]. When the heart is involved, amyloid infiltration 
is generalised: ventricular and atrial myocardium, vascula-
ture, conduction system and valves are equally affected. In 
95% of  patients with cardiac amyloidosis other organs or 
tissues are also affected, so signs or symptoms of  extra-
cardiac manifestations should not be ignored[3-5].
Electrocardiography usually shows low voltages in the 
limb leads and poor R wave progression in the precordial 
leads. Due to amyloid infiltration in the conduction sys-
tem, several conduction disorders and arrhythmias can 
occur. Reduced myocardial relaxation is an early echocar-
diographic finding that usually progresses into restrictive 
patterns. There may also be left ventricular hypertrophy, 
granular sparkling, atrial dilation, valvular thickening and 
pericardial effusion[3-5]. 
The diagnosis of  systemic amyloidosis can be con-
firmed by SAP scintigraphy and Congo red staining of  
abdominal fat aspiration biopsy[3-5]. Immunohistochemi-
cal staining determines the kind of  protein from which 
the amyloid originates. When abdominal fat aspiration bi-
opsy does not result in diagnosis, endomyocardial biopsy 
should be considered. The latter has a sensitivity of  near 
100%. Plasma cell dyscrasia in a bone marrow biopsy 
and free lambda or kappa (less common) light chains in 
serum and/or urine samples then confirm the diagnosis 
AL-amyloidosis[3-5].
This case shows the rapid decline in clinical condi-
tion with the progression of  cardiac involvement in AL-
amyloidosis[5]. Regardless of  the method of  treatment, 
cardiac involvement in AL-amyloidosis generally denotes 
a poor prognosis,. As in our patient, the median survival 
rate from the onset of  symptoms of  congestive heart 
failure is only 6 mo [6].
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Figure 3  Abdominal subcutaneous fat aspirate of the patient stained with 
Congo red, magnification x 30. Amyloid score 3+ (10%-60% of the surface is 
occupied by amyloid). A: When viewed in normal light, amyloid is stained red; 
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